Current Opinion in Nephrology & Hypertension,
Journal Year:
2019,
Volume and Issue:
28(4), P. 397 - 405
Published: March 29, 2019
Acute
kidney
injury
(AKI)
remains
a
major
unmet
medical
need
and
associates
with
high
morbidity,
mortality,
healthcare
costs.
Among
survivors,
long-term
outcomes
of
AKI
can
include
development
chronic
disease
(CKD)
or
progression
preexisting
CKD.
In
this
review,
we
focus
on
ongoing
efforts
by
the
community
to
understand
human
CKD
continuum,
an
emphasis
cellular
stress
responses
that
underlie
maladaptive
persist
in
acute-to-chronic
phase.
The
is
work
has
been
published
past
year
rapidly
expanding
field.Recent
studies
preclinical
models
highlight
importance
mitochondrial
dysfunction,
cell
death,
inflammation
underlying
pathogenesis
AKI.
These
pathogenic
mechanisms
resolve
adaptive
repair
but
leads
progressive
disease.
complexity
interconnections
these
pathways
involve
cross-talk
between
tubular
epithelium,
endothelium,
interstitial
compartments.Approaches
which
lessen
counteract
represent
novel
strategies
prevent
stop
slow
down
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: March 17, 2023
Abstract
Chronic
kidney
disease
(CKD)
is
estimated
to
affect
10–14%
of
global
population.
Kidney
fibrosis,
characterized
by
excessive
extracellular
matrix
deposition
leading
scarring,
a
hallmark
manifestation
in
different
progressive
CKD;
However,
at
present
no
antifibrotic
therapies
against
CKD
exist.
fibrosis
identified
tubule
atrophy,
interstitial
chronic
inflammation
and
fibrogenesis,
glomerulosclerosis,
vascular
rarefaction.
Fibrotic
niche,
where
organ
initiates,
complex
interplay
between
injured
parenchyma
(like
tubular
cells)
multiple
non-parenchymal
cell
lineages
(immune
mesenchymal
located
spatially
within
scarring
areas.
Although
the
mechanisms
are
complicated
due
kinds
cells
involved,
with
help
single-cell
technology,
many
key
questions
have
been
explored,
such
as
what
kind
renal
tubules
profibrotic,
myofibroblasts
originate,
which
immune
how
communicate
each
other.
In
addition,
genetics
epigenetics
deeper
that
regulate
fibrosis.
And
reversible
nature
epigenetic
changes
including
DNA
methylation,
RNA
interference,
chromatin
remodeling,
gives
an
opportunity
stop
or
reverse
therapeutic
strategies.
More
marketed
(e.g.,
RAS
blockage,
SGLT2
inhibitors)
developed
delay
progression
recent
years.
Furthermore,
better
understanding
also
favored
discover
biomarkers
fibrotic
injury.
review,
we
update
advances
mechanism
summarize
novel
treatment
for
CKD.
Cell Death and Disease,
Journal Year:
2021,
Volume and Issue:
12(2)
Published: Feb. 15, 2021
Abstract
Chemotherapy
drug-induced
nephrotoxicity
limits
clinical
applications
for
treating
cancers.
Pyroptosis,
a
newly
discovered
programmed
cell
death,
was
recently
reported
to
be
associated
with
kidney
diseases.
However,
the
role
of
pyroptosis
in
chemotherapeutic
has
not
been
fully
clarified.
Herein,
we
demonstrate
that
drug
cisplatin
or
doxorubicin,
induces
cleavage
gasdermin
E
(GSDME)
cultured
human
renal
tubular
epithelial
cells,
time-
and
concentration-dependent
manner.
Morphologically,
cisplatin-
doxorubicin-treated
cells
exhibit
large
bubbles
emerging
from
membrane.
Furthermore,
activation
caspase
3,
9,
is
GSDME
cells.
Meanwhile,
silencing
alleviates
doxorubicin-induced
HK-2
by
increasing
viability
decreasing
LDH
release.
In
addition,
treatment
Ac-DMLD-CMK,
polypeptide
targeting
mouse
3-Gsdme
signaling,
inhibits
3
Gsdme
activation,
deterioration
function,
attenuates
injury,
reduces
inflammatory
cytokine
secretion
vivo.
Specifically,
depends
on
ERK
JNK
signaling.
NAC,
reactive
oxygen
species
(ROS)
inhibitor,
through
signaling
Thus,
speculate
induced
chemotherapy
drugs
mediated
ROS-JNK-caspase
3-GSDME
implying
therapies
may
prove
efficacious
overcoming
nephrotoxicity.
Cell Death and Disease,
Journal Year:
2021,
Volume and Issue:
12(9)
Published: Sept. 11, 2021
Abstract
Renal
fibrosis
is
a
common
pathological
process
that
occurs
with
diverse
etiologies
in
chronic
kidney
disease.
However,
its
regulatory
mechanisms
have
not
yet
been
fully
elucidated.
Ferroptosis
form
of
non-apoptotic
regulated
cell
death
driven
by
iron-dependent
lipid
peroxidation.
It
currently
unknown
whether
ferroptosis
initiated
during
unilateral
ureteral
obstruction
(UUO)-induced
renal
and
role
has
determined.
In
this
study,
we
demonstrated
induced
tubular
epithelial
cells
(TECs)
vivo.
The
inhibitor
liproxstatin-1
(Lip-1)
reduced
iron
deposition,
death,
peroxidation,
inhibited
the
downregulation
GPX4
expression
UUO,
ultimately
inhibiting
TECs.
We
found
Lip-1
significantly
attenuated
UUO-induced
morphological
changes
collagen
deposition
mice.
addition,
profibrotic
factors
UUO
model.
vitro,
used
RSL3
treatment
knocked
down
level
RNAi
HK2
to
induce
ferroptosis.
Our
results
indicated
secreted
various
was
able
inhibit
thereby
secretion
process.
Incubation
fibroblasts
culture
medium
from
RSL3-induced
promoted
fibroblast
proliferation
activation,
whereas
impeded
effects.
study
may
relieve
Mechanistically,
could
reduce
activation
surrounding
paracrine
cells.
potentially
be
as
therapeutic
approach
for
fibrosis.
Overwhelming
lipid
peroxidation
induces
ferroptotic
stress
and
ferroptosis,
a
non-apoptotic
form
of
regulated
cell
death
that
has
been
implicated
in
maladaptive
renal
repair
mice
humans.
Using
single-cell
transcriptomic
mouse
genetic
approaches,
we
show
proximal
tubular
(PT)
cells
develop
molecularly
distinct,
pro-inflammatory
state
following
injury.
While
these
inflammatory
PT
transiently
appear
after
mild
injury
return
to
their
original
without
inducing
fibrosis,
severe
they
accumulate
contribute
persistent
inflammation.
This
transient
significantly
downregulates
glutathione
metabolism
genes,
making
the
vulnerable
stress.
Genetic
induction
high
leads
accumulation
cells,
enhancing
inflammation
fibrosis.
Our
study
broadens
roles
from
being
trigger
include
promotion
proinflammatory
underlie
repair.
Annals of Intensive Care,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: July 2, 2022
Abstract
Background
Post‐intensive
care
syndrome
(PICS)
encompasses
physical,
cognition,
and
mental
impairments
persisting
after
intensive
unit
(ICU)
discharge.
Ultimately
it
significantly
impacts
the
long‐term
prognosis,
both
in
functional
outcomes
survival.
Thus,
survivors
often
develop
permanent
disabilities,
consume
a
lot
of
healthcare
resources,
may
experience
prolonged
suffering.
This
review
aims
to
present
multiple
facets
PICS,
decipher
its
underlying
mechanisms,
highlight
future
research
directions.
Main
text
abridges
translational
data
chronic
critical
illness
(CCI)
PICS.
We
focus
first
on
ICU-acquired
weakness,
characterized
by
impaired
contractility,
muscle
wasting,
atrophy
during
recovery
phase,
which
involves
anabolic
resistance,
capacity
regeneration,
mitochondrial
dysfunction,
abnormalities
calcium
homeostasis.
Second,
we
discuss
clinical
relevance
post-ICU
cognitive
impairment
neuropsychological
disability,
association
with
delirium
ICU
stay,
putative
role
low-grade
long-lasting
inflammation.
Third,
describe
profound
persistent
qualitative
quantitative
alteration
innate
adaptive
response.
Fourth,
biological
mechanisms
progression
from
acute
kidney
injury,
opening
field
for
renoprotective
strategies.
Fifth,
report
pulmonary
consequences
ARDS
mechanical
ventilation.
Finally,
several
specificities
children,
including
influence
child’s
pre-ICU
condition,
development,
maturation.
Conclusions
Recent
understandings
substratum
PICS’
distinct
features
need
rethink
our
patient
trajectories
long
term.
A
better
knowledge
this
precipitating
factors
is
necessary
protocols
strategies
alleviate
CCI
PICS
ultimately
improve
recovery.